Anebulo rises as it weighs going-private deal after getting fresh options

Anebulo Pharmaceuticals

12/09/2025 14:34

** Shares of drug developer Anebulo Pharmaceuticals ANEB.O rise 16.9% to $2.35 in early morning trading

** Anebulo Pharmaceuticals says it is still considering a plan to go private after it first announced it in July 2025, but has also received interest from possible buyers and partners

** The company's board will review different options to maximize shareholder value, including the going-private deal with a reverse stock split, a potential sale of its assets, or a merger, the company says

** As of last close, ANEB was down 19.6% YTD

 (Reporting by Padmanabhan Ananthan)

 ((Padmanabhan.Ananthan@thomsonreuters.com))